chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine was expired on 24-Oct-2021 and was administered to the patient on 25-Oct-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 24-Oct-2021 and was administered to the patient on 25-Oct-2021) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 24-Oct-2021 and was administered to the patient on 25-Oct-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 24-Oct-2021 and was administered to the patient on 25-Oct-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported. Date the vial was initially stored in the refrigerator was unknown. Expiration date was reported as 24-Oct-2021. The vial did not undergo any temperature excursions. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received reporter address updated.
Info has been received from a physician concerning an 11 year old female who was vaccinated with a dose of varicella virus vaccine live. In July 2005, the pt developed shingles. Unspecified medical attention was sought. The pt's status was unknown. There was no product quality complaint involved. Additional info has been requested.
The patient reports that since vaccination he hasn't been able to use his hand as well as before in the right hand.  He attributes it to vaccination.  He said that he isn't able to grip things the same way, and that it "feels funny."  He reports being able to feel with his hand, and denies numbness.
first dose over a year ago, has not received a second dose yet.; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose of Shingrix received just over a year ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of vaccine, which led to incomplete course of vaccination.  The vaccine administration facility was the same as primary reporter. Consented to follow up was denied.
Per patient report, patient stated she received vaccinations in left shoulder/arm and then afterwards, arm swelled and patient still in pain. PCP told patient she has a pinched nerve. Unclear whether any further treatment will be given to patient but pharmacy will follow up with PCP.
Transverse Myelitis; This is a spontaneous report from a contactable pharmacist. A 40-years-old adult male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: El3249) via an intramuscular route of administration in Arm Right on 20Jan2021 03:15 (age at vaccination 40years old) as Dose 2,Single for COVID-19 immunization. Medical history included diabetes mellitus from an unknown date and unknown if ongoing, hypertension from an unknown date and unknown if ongoing, HTN, hyperlipidaemia from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility the most recent COVID-19 vaccine was administered in Workplace clinic. Concomitant medication(s) included semaglutide (OZEMPIC); metformin (METFORMIN); hydrochlorothiazide, losartan potassium (HYZAAR); rosuvastatin calcium (CRESTOR). All taken for an unspecified indication, start and stop date were not reported. The patient was allergic to the drug Amoxil.Since the vaccination, the patient had not been tested positive for COVID-19. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: El0142) via an intramuscular route of administration in Arm Right on 30Dec2020 03:15 as Dose 1,Single for COVID-19 immunization. The patient experienced transverse myelitis in Jun2021. The patient was hospitalized for transverse myelitis for 3 days. The patient received any treatment for the adverse events. Therapeutic measures were taken as a result of transverse myelitis. The clinical outcome of the event recovering.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the reported information ,a causal relationship between the events and suspected drug cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
FAINTING; VOMITING BLOOD; SHORTNESS OF BREATH; RACING HEARTBEAT; CHEST PAIN; VOMITING; COLD CHILLS; NAUSEA; FEVER; HEADACHE; This spontaneous report received from a consumer concerned a 31-year-old male patient of unspecified race and ethnic origin.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration was not reported, batch number: unknown, expiry date: unknown) dose, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced shortness of breath, racing heartbeat, chest pain, vomiting blood, vomiting, cold chills, nausea, fainting, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, fever, cold chills, shortness of breath, racing heartbeat, chest pain, fainting, nausea, vomiting and vomiting blood was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210633054.; Sender's Comments: V0: 20210630836- covid-19 vaccine ad26.cov2.s -Fainting, vomiting blood. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Light headed; lack of appetite; achy; nauseous; sick feeling; This is a spontaneous report from a contactable consumer (Patient). A 73-Year-old female patient received first dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine, lot number EH9899), via an unspecified route of administration at Arm Right on 07Jan2021 10:30 at the 73 years old at single dose for COVID-19 immunization.  The medical history was none. The concomitant medications were vitamin C (ascorbic acid), atorvastatin (strength 5 mg), valsartan (strength 80 mg). There was no other vaccine in four weeks. On15Jan2021 08:00 the patient experienced Light headed, lack of appetite, achy, nauseous, sick feeling. The events were continuing though lighter for at least another 3 days. There was no treatment received for all the adverse events.  The patient had no Covid prior vaccination. There was covid tested post vaccination. The patient underwent lab tests and procedures, which included Nasal Swab negative on 18Jan2021.  The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This case was reported by a pharmacist via call center representative and described the occurrence of numbness facial in a female patient who received SHINGRIX for prophylaxis. Concomitant products included FLUZONE. On 11th September 2018, the patient received SHINGRIX. On 13th September 2018, 2 days after receiving SHINGRIX, the patient experienced numbness facial. On an unknown date, the outcome of the numbness facial was not recovered/not resolved. It was unknown if the reporter considered the numbness facial to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. On 6th September 2018, the patient was vaccinated with FLUZONE vaccine. The healthcare professional did not want to provide any further information. The reporter did not knew which vaccine caused the reaction so she was contacted all the pharmaceutical companies involved before providing further information.
Patient was scheduled on 08/19/2021 to receive second dose, however, as was written on her vaccine card a date of 08/09/2021, patient arrived on this day. Patient was administered dose and nurse realized afterwards that it was the incorrect date of administration.
Salivary Gland disfunction, and Oral Inflammation in lower mouth and Lymph Glands.  Headache. Blood bruise weeping down left arm. Headache resolved after two days and was treatable with Ibuprofin. Salivary disfunction alternated between steady flowing salivation causing coughing at night, to Zero Salivation causing dry burning and oral pain.  It was possible to force salivation once awake.  This continued for four days and then stopped. Throat Lymph swelling and mouth pain continued for two weeks, and reoccurred after 4 weeks. Lymph Swelling resolved after July 4th, but a lump remained on the left side of the throat but seems to decreasing.
After the COVID vaccine, the mother reports having a sore arm, which she felt was normal.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "After the COVID vaccine, the mother reports having a sore arm, which she felt was normal.". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
extreme fatigue, missed many work days sleeping approx 16 hours a day. Second vaccine end of Jan 2021. Had to go on unpaid leave from 02/23/2021, resigned from job 05/03/2021
On 4/12/2021, I began experiencing migraine-like symptoms: bad headache and irritated nerves at back of neck. By 4/14/2021, I had a small sore at the corner of my left eye, which at the time I thought was an outbreak of herpes (which I also have, and have had near my eye before). However, the symptoms got worse. By 4/16/2021, I had a second sore appear near my cheekbone and intense itching on my face, with nerve pain in my face. By the morning of 4/17/2021, I woke up with my left eyelid swollen and redness in my left eye, which led me to seek medical attention at an urgent care facility. At urgent care, was diagnosed with shingles with concern of eye involvement. Was prescribed valcyclovir and an antibiotic eyedrop, ofloxacin. Follow up appointment with an opthamologist has been booked.
All over body soreness and fever one day after (Thursday) 2 days after (today) severe swelling under my eyes where I had juvederm cheek filler injected over 2 years prior (2019)
Severe Fatigue, Severe Depression: Slept for over 2 days, only awake few hours at a time, drastically worsening depression within hours of vaccination- regularly prescribed medication did not alleviate symptoms, suicidal ideation, radiating pain from injection site to back and neck
Redness, swelling resulting in mild cellulitis: treating with Augmentin ES 600/5
I had a runny nose, a dry cough, high fever I tested because a friend of mine called to let me know that she had tested positive. I took a home COVID-19 test, it came back positive immediately. I called my doctor to let him know I had tested positive for COVID-19. He gave me a prescription for TESSALON PERLES, advised me to pick up MUCINEX DM, take TYLENOL as needed. I was feeling better within five days.
Left deltoid muscle soreness from the first day.  After 3 weeks,  the pain extended to the left biceps, triceps, AC joint. Pain gradually worsened and frozen shoulder developed. Fell once after 4 months and developed swelling over left clavicle. Left shoulder MRI on 4-21-22 showed severe capsulitis, partial tear of subscapularis. Neck and Chest CT scans for left supraclavicular swelling, neck and chest pain were negative 5-17-2022. Left shoulder  steroid injection given on 5-5-22. Persistent frozen shoulder, swelling over left scapula and left supraclavicular areas which may be synovial fluid collections.  Physical therapy started 5-6-22.
My son received his 4th DTAP vaccine on 4/25/17 and within 24 hours developed cold like symptoms...this was very common after almost all vaccines...but never related it to vaccine injury until now...on 05/07/17 he developed a fever and was very lethargic...on 05/08/17 he seemed to be completely back to himself...on 05/12/17 I found him in his crib at 08:30 AM...he passed away that prior evening...
Woke up uncontrollably shaking with a migraine (10 out of 10 on a pain scale).  Took ibuprofen, then nurtec. By 8am I took a imitrex injection. At 12pm I took an imitrex tablet.
patient who was 17 at time of dose received adult dose of moderna, mother reports pt experienced fever and chills for 2 days only, and is asymptomatic, no apparent distress. mother expressed understanding.
> Summary: DVT left leg.  Details: Left lower leg and ankle swelled during each day starting 7 days after second Moderna shot, but patient did not see doctor about it until it got uncomfortable five months later.  Diagnosis was DVT. (There was no injury or long vehicle drives prior to cause this.)  Prescribed Eliquis (apixaban) and a compression stocking.  Improvement shown in test on 12/13/2021. (Note: also have a reported event on 3/16/2021 after previous first dose.)
t104 R 12 hrs p/vax given; sleepiness 24 hrs p/vax were given; nausea, vomiting, shaking 2 days p/vax were given which lasted 3-4 hrs; did not have any redness or swelling @ inject site;
No additional AEs reported; GARDASIL 9 was administered following a temperature excursion; This spontaneous report was received from an office manager referring to a 14-year-old male patient.  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 07-MAR-2023, the patient was vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe injection, administered as prophylaxis (there were five possible lot # of the vaccine administered: lot #1775811, expiration date: 07-DEC-2023; lot #1775827, expiration date: 27-JUN-2024; lot #W009829, expiration date: 19-OCT-2024; lot #U032681, expiration date: 26-OCT-2023; and lot #1780876, expiration date: 09-NOV-2023; however, it was not specified which one was received by the patient) (strength, dose, route of administration, anatomical location, and vaccination scheme were not provided). It was reported that the vaccines suffered from three temperature excursions with a total of 25 minutes (on 09-SEP-2022 for 8 minutes; on 16-SEP-2022 for 5 minutes; and on 03-JAN-2023 for 12 minutes). The excursions were not noted until it was noticed that an employee mistakenly cleaned the data logger more than once a day (product storage error). There were no additional adverse events (AEs) reported in the patient (no adverse event).  This is one of several reports received from the same reporter.
no adverse event; Expired vaccine used; This spontaneous report was received from a medical assistant referred to a 41-year-old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.  On 11-APR-2023, the patient was vaccinated an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 dose, lot #U036184, expiration date: 02-MAR-2023, for prophylaxis (strength, and route of administration were not provided) (Expired product administered). It was confirmed that no other adverse event occurred (no adverse event), and the product did not have any temperature excursions prior to administration.
1 day p/vax devel rash on arms, face, neck, red, itchy, blisters-scabs (looks like contact dermatitis);
pain in his arm; the patient received 0.7 mL dose; Initial information received on 06-Oct-2020 regarding an unsolicited valid non-serious case from a pharmacist.  This case involves a 79 years old male patient who experienced pain in his arm (pain in extremity), while he received vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's medical history, past medical treatment, past vaccination and family history were not provided. Concomitant medication were not reported.  On 24-Sep-2020, the patient received a 0.7 mL dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot: UJ499AA, expiry date: 30-Jun-2021) via an unknown route at an unknown administration site as prophylactic vaccination.  On an unknown date, the patient developed a non-serious pain in his arm (pain in extremity) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  It was also a case of overdose.  Laboratory details were not reported.  It was not reported if the patient received any corrective treatment.  The event outcome was unknown for pain in extremity.
Received influenza and pneumonia vaccine on 11/04/08.  Left forearm pneumonia site and red and warm to touch.  Redness and warmth has radiated to posterior area.  Has applied ice packs but very painful.  Physician referred to hospital ER to evaluate possibility of cellulitis.  Reports problem started immediately after receiving injection.
About 5 minutes of patient receiving 2nd dose Moderna Vaccine, patient stated experiencing dizziness, light headed and flushing.  1st set of vitals are the following O2: 99%, HR:48, BP 110/72.  A cold pack and a bottle of water was provided.  Last set of vitals are O2:99%, HR: 68, BP: 124/74.  Patient stated she was feeling better.  Patient was leaving site at 3:21pm.
Received shot, how long before I feel better; This case was reported by a consumer via interactive digital media and described the occurrence of feeling unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was not recovered/not resolved.   It was unknown if the reporter considered the feeling unwell to be related to Shingles vaccine.     Additional Information: GSK receipt date: 24-AUG-2022 Reporter's comments: This case was reported from the patient via interactive digital media. It was reported that patient received the Shingles shot and patient enquired how long it would take before patient feels better. Additional Supportive Information: Follow-up would not possible as no contact details were available.
This spontaneous report as received from registered nurse refers to a 1 year old child patient (gender not provided). Patient medical history and other previous drug allergic reactions were not reported. On an unknown date, the patient was vaccinated with VARIVAX (Merck) (dose number, lot number and expiry date unknown), that was exposed to additional temperature excursions since 07-NOV-2014. No adverse events were reported. The registered nurse stated that there were no adverse events reported of the patients who had received the vaccinations. The reporter did not have lot numbers or expiration dates readily available at the time of contact. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unregistered number of patients of unknown age and gender. On an unknown dates, the patients were vaccinated with improperly doses of ZOSTAVAX (route, dose and lot # not reported). The temperature excursion for ZOSTAVAX was unsupported with in house stability data. No adverse symptoms were reported. This is one of several reports received from the same source. Additional information has been requested.
Information was received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. During January of 2011, the patient was inoculated with ZOSTAVAX (lot number, dosage, and route of administration not provided), at a clinic (by an unspecified healthcare professional), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 15-JUN-2016, the patient was treated at a medical center (by an unspecified healthcare professional) for the onset of a vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.  The reporter considered the events to be related to ZOSTAVAX. The outcome of the events was unknown. Additional information has been requested.
The day after the shot, my arm ached, I was nauseous and fainted. I fainted again day 2 after the shot. After that, I was fine.
symptoms started with loosing sensation in feet/legs then charlie horses at night in calves, continued to loss of sensation, tingling and burning in feet traveling up legs then to hands arms, exhaustion, bubbling excema like outbreaks on hands that don't go away, other inflammatory/auto immune type symptons like joint pain, muscle pain, loss of flexibility, difficulty with balance at times, sleep disturbances  - have been on hydroxychloroquine, gabapentin and prednisone, multiple supplements, anti inflammatory diet, acupuncture - all medical records can be shared